Videos de Experimentos Relacionados
Patentar el ADN complementario es patentar el ADN complementario.
Science (New York, N.Y.)
|April 3, 1992
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
COVID-19 restrictions and recreational fisheries in Ontario, Canada: Preliminary insights from an online angler survey.
Fisheries research·2022
Same author
Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation.
Journal of controlled release : official journal of the Controlled Release Society·2021
Same author
Retraction notice to " IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas" [Canc. Lett., 458 (2019) pages 29-38].
Cancer letters·2021
Same author
Corrigendum to "IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas." [Cancer Lett. 458C (2019) 29-38].
Cancer letters·2019
Same author
RETRACTED: IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.
Cancer letters·2019
Same author
Ikaros transcripts Ik6/10 and levels of full-length transcript are critical for chronic myeloid leukaemia blast crisis transformation.
Leukemia·2014
Same journal
Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".
Science (New York, N.Y.)·2026